Genentech Settles FCA Suit Over Cancer Drug For $20M
The settlement, which calls for Genentech to pay the $20 million to the U.S., was reached last week, according to court documents. U.S. District Judge Paul Diamond dismissed the suit with prejudice, putting an end to the eight-year case.
The qui tam suit was brought by former Genentech employee John Underwood, who...
To view the full article, register now.